Background: After small-for-size graft (SFSG) transplantation, elevated portal venous pressure (PVP) may lead to postoperative liver damage. Herein we evaluated the impact of portocaval shunt (PCS) to control PVP on liver grafts and intestine following SFSG transplantation. Methods: Nineteen SFSG transplantations were performed with 30% of native liver in swine. Swine were divided into 3 groups: a high-flow shunt group (HS: n = 7), in which portal venous flow (PVF) was reduced with a 10-mm diameter PCS; a low-flow shunt group (LS: n = 6), in which PVF was reduced with a 5-mm diameter PCS, and a no-shunt group (NS: n = 6), in which no PCS was placed. Results: Seven-day survivals were 83.3% in NS, 100% in LS and 0% in HS (p = 0.0088). PVP was significantly higher in the NS group (p = 0.0001; mean ± SEM NS/LS/HS: 20.5 ± 0.7/14.0 ± 1.2/11.6 ± 0.5 mm Hg). The LS group exhibited the highest compliance (PVF/PVP; NS/LS/HS 42.7 ± 10.9/44.6 ± 4.9/37.7 ± 8.3 ml/min/mm Hg; p = 0.009), the lowest aspartate aminotransferase (NS/LS/HS 562 ± 18/370 ± 55/720 ± 130 IU/l; p = 0.0493), and suppressed deleterious alternations of the hepatic parenchyma and intestinal mucosa. Conclusions: Portal hypertension after SFSG transplantation impaired liver and intestinal mucosa; however, inadequate portal flow impaired not only the liver, but also survival.

1.
Kiuchi T, Kasahara M, Uryuhara K, Inomata Y, Uemoto S, Asonuma K, et al: Impact of graft size mismatching on graft prognosis in liver transplantation from living donors. Transplantation 1999;67:321–327.
2.
Ikegami T, Shimada M, Imura S, Arakawa Y, Nii A, Morine Y, et al: Current concept of small-for-size grafts in living donor liver transplantation. Surg Today 2008;38:971–982.
3.
Fan ST, Lo CM, Liu CL, Wang WX, Wong J, Peitgen HO, et al: Safety and necessity of including the middle hepatic vein in the right lobe graft in adult-to-adult live donor liver transplantation. Ann Surg 2003;238:137–148.
4.
Kasahara M, Takada Y, Fujimoto Y, Ogura Y, Ogawa K, Uryuhara K, et al: Impact of right lobe with middle hepatic vein graft in living-donor liver transplantation. Am J Transplant 2005;5:1339–1346.
5.
Asakuma M, Fujimoto Y, Bourquain H, Uryuhara K, Hayashi M, Tanigawa N: Graft selection algorithm based on congestion volume for adult living donor liver transplantation. Am J Transplant 2007;7:1788–1796.
6.
Yu Y, Lv L, Qian X, Chen N, Yao A, Pu LY, et al: Antifibrotic effect of hepatocyte growth factor-expressing mesenchymal stem cells in small-for-size liver transplant rats. Stem Cells Dev 2010;19:903–914.
7.
Troisi R, Cammu G, Militerno G, De Baerdemaeker L, Decruyenaere J, Hoste E, et al: Modulation of portal graft inflow: a necessity in adult living-donor liver transplantation? Ann Surg 2003;237:429–436.
8.
Takada Y, Ueda M, Ishikawa Y, Fujimoto Y, Miyauchi H, Ogura Y, et al: End-to-side portocaval shunting for a small-for-size graft in living donor liver transplantation. Liver Transpl 2004;10:807–810.
9.
Yamada T, Tanaka K, Uryuhara K, Ito K, Takada Y, Uemoto S: Selective hemi-portocaval shunt based on portal vein pressure for small-for-size graft in adult living donor liver transplantation. Am J Transplant 2008;8:847–853.
10.
Shimada M, Ijichi H, Yonemura Y, Harada N, Shiotani S, Ninomiya M, et al: The impact of splenectomy or splenic artery ligation on the outcome of a living donor adult liver transplantation using a left lobe graft. Hepatogastroenterology 2004;51:625–629.
11.
Oura T, Taniguchi M, Shimamura T, Suzuki T, Yamashita K, Uno M, et al: Does the permanent portacaval shunt for a small-for-size graft in a living donor liver transplantation do more harm than good? Am J Transplant 2008;8:250–252.
12.
Hashimoto N, Ohyanagi H: Effect of acute portal hypertension on gut mucosa. Hepatogastroenterology 2002;49:1567–1570.
13.
Quigley M: Bacterial translocation in acute and chronic portal hypertension. Hepatology 1994;20:264–266.
14.
Wang XD, Guo WD, Wang Q, Andersson R, Ekblad E, Soltesz V, et al: The association between enteric bacterial overgrowth and gastrointestinal motility after subtotal liver resection or portal vein obstruction in rats. Eur J Surg 1994;160:153–160.
15.
Wang X, Andersson R, Soltesz V, Wang L, Bengmark S: Effect of portal hypertension on bacterial translocation induced by major liver resection in rats. Eur J Surg 1993;159:343–350.
16.
Garcia-Tsao G, Albillos A, Barden GE, West AB: Bacterial translocation in acute and chronic portal hypertension. Hepatology 1993;17:1081–1085.
17.
Yao GX, Shen ZY, Xue XB, Yang Z: Intestinal permeability in rats with CCl4-induced portal hypertension. World J Gastroenterol 2006;12:479–481.
18.
Park PO, Haglund U, Bulkley GB, Falt K: The sequence of development of intestinal tissue injury after strangulation ischemia and reperfusion. Surgery 1990;107:574–580.
19.
Kiuchi T, Tanaka K, Ito T, Oike F, Ogura Y, Fujimoto Y, et al: Small-for-size graft in living donor liver transplantation: how far should we go? Liver Transpl 2003;9:S29–S35.
20.
Boillot O, Mechet I, Le Derf Y, Bernard P, Figueiredo P, Berger F, et al: Portomesenteric disconnection for small-for-size grafts in liver transplantation: preclinical studies in pigs. Liver Transpl 2003;9:S42–S46.
21.
Pouyet M, Paquet C: Effect of mesocaval shunt on survival of small-for-size liver grafts. Transplantation 2004;77:952.
22.
Kawasaki T, Moriyasu F, Kimura T, Someda H, Fukuda Y, Ozawa K: Changes in portal blood flow consequent to partial hepatectomy: Doppler estimation. Radiology 1991;180:373–377.
23.
Iida T, Yagi S, Taniguchi K, Hori T, Uemoto S: Improvement of morphological changes after 70% hepatectomy with portocaval shunt: preclinical study in porcine model. J Surg Res 2007;143:238–246.
24.
Yagi S, Iida T, Taniguchi K, Hori T, Hamada T, Fujii K, et al: Impact of portal venous pressure on regeneration and graft damage after living-donor liver transplantation. Liver Transpl 2005;11:68–75.
25.
Hessheimer AJ, Fondevila C, Taura P, Munoz J, Sanchez O, Fuster J, et al: Decompression of the portal bed and twice-baseline portal inflow are necessary for the functional recovery of a ‘small-for-size’ graft. Ann Surg 2011;253:1201–1210.
26.
Ogura Y, Hori T, El Moghazy WM, Yoshizawa A, Oike F, Mori A, et al: Portal pressure <15 mm Hg is a key for successful adult living donor liver transplantation utilizing smaller grafts than before. Liver Transpl 2010;16:718–728.
27.
Shimamura T, Taniguchi M, Jin MB, Suzuki T, Matsushita M, Furukawa H, et al: Excessive portal venous inflow as a cause of allograft dysfunction in small-for-size living donor liver transplantation. Transplant Proc 2001;33:1331.
28.
Yagi S, Iida T, Hori T, Taniguchi K, Yamamoto C, Yamagiwa K, et al: Optimal portal venous circulation for liver graft function after living-donor liver transplantation. Transplantation 2006;81:373–378.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.